The first Gene Therapy Treatment Approved by the FDA.
For Hemophilia B Patients
This is a regional virtual educational event for our hemophilia B patient/family population on the recently approved gene therapy for hemophilia B, HEMGENIX. It is a one-hour presentation delivered by a healthcare professional trained in this treatment and its presentation information. We wish to inform and educate the hemophilia population about this new treatment so that you are better prepared to discuss options with HTC(s) and/or healthcare provider(s).
